Clinical Trial Update: A Study of Pembrolizumab in Japanese Pediatric Participants With Solid Tumors or Lymphomas and Japanese Adult Participants With Merkel Cell Carcinoma (MK-3475-G21/KEYNOTE-G21) [Phase 1, Phase 2]

View source ↗

Summary

A multi-phase clinical trial evaluating pembrolizumab in Japanese pediatric participants with solid tumors or lymphomas and Japanese adult participants with Mer…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Lymphoma
• Merkel Cell Carcinoma

Drugs mentioned

• Pembrolizumab (pembrolizumab)

Snippet

Sponsor: Merck Sharp & Dohme LLC | Conditions: Malignant Neoplasm, Carcinoma, Merkel Cell | Phase 1, Phase 2 | Status: RECRUITING